Stay updated with breaking news from Alpine Immune Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
20.03.2023 - Alpine Immune Sciences, Inc. (NASDAQ: ALPN), a leading clinical-stage immunotherapy company focused on developing innovative treatments for autoimmune and inflammatory diseases, will present posters at the American Society for Clinical Pharmacology ... Seite 1
ZeroHedge - On a long enough timeline, the survival rate for everyone drops to zero
22.11.2022 - Alpine Immune Sciences, Inc. (NASDAQ: ALPN), a leading clinical-stage immunotherapy company focused on developing innovative treatments for autoimmune and inflammatory diseases, today announced the Company will participate in a fireside chat at the ...
Item 2.02 Results of Operations and Financial Condition. On November 14, 2022, Alpine Immune Sciences, Inc. issued a press release reporting its financial results for the three and nine months... | November 14, 2022
/PRNewswire/ -- DelveInsight's 'PD-1 and PD-L1 Inhibitors Competitive Landscape – 2022' report provides comprehensive global coverage of available, marketed,...